Child Mortality Clinical Trial
Official title:
Scaling Up Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA
The investigators will assess whether in Bushenyi District in southwestern Uganda, a two
year intervention providing comprehensive MNCH programming will:
- Reduce morbidity and mortality for children under five years old and;
- Improve access to maternal health services Compared to a control community without MNCH
intervention?
Hypothesis:
Comprehensive maternal, newborn and child health programming in Bushenyi Distrcit can have a
positive impact on morbidity and mortality for children under five years and will improve
access for women to maternal health services which may lead, in the longer term, to
decreased maternal mortality.
A detailed impact assessment will be carried out for the duration of the MNCH training and
support initiative in Bushenyi District, using mixed methods. The study will assess 8 of the
11 key core MNCH indicators as identified by CIDA as a priority. Other information to be
collected such as demographics and patterns of health care use, and prevalence of disease
will help health planners in the districts, and will be helpful in sub analysis and
interpretation of findings. The main study will use household surveys in both districts at
baseline, midline and endline. Other tools will include pre and post qualitative surveys
(FGDs, KII) and analysis of operational data.
The main study group will be representative communities and health centres within Bushenyi
District who will receive intervention between 2012 and 2014; Rubirizi District will serve
as a control area for this study but will received selected MNCH services starting in 2013
after midline data are collected.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04716712 -
Infant Mortality Reduction by the Mass Administration of Azithromycin
|
Phase 4 | |
| Completed |
NCT02943681 -
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
|
N/A | |
| Completed |
NCT02233127 -
Birth Cohort in Rahimyar Khan, Pakistan
|
N/A | |
| Completed |
NCT03676751 -
MORDOR II Burkina Faso: Longitudinal Trial
|
Phase 4 | |
| Completed |
NCT04617626 -
Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire
|
N/A | |
| Completed |
NCT03367832 -
South African Paediatric Surgical Outcomes Study (SAPSOS)
|
N/A | |
| Recruiting |
NCT00656591 -
Community-Based Interventions for Infant Health in Nepal
|
Phase 1 | |
| Recruiting |
NCT04235816 -
Improving Care Through Azithromycin Research for Infants in Africa
|
Phase 3 | |
| Recruiting |
NCT05016895 -
REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire
|
N/A |